🇺🇸 FDA

Company profile · Sponsor

Immunitybio

Immunitybio Ireland Limited

E2736F2 · EMA pharma GB
Pipeline
1
Drugs
0
Patents
0

Quick answer

Immunitybio (E2736F2) is a pharma company. headquartered in GB. listed on EMA. NovaPharmaNews links 1 pipeline program, 0 drugs, and 0 patents to this profile..

Company facts

Ticker E2736F2
Exchange EMA
Company type pharma
Headquarters GB

Pipeline (1)

Search pipeline →

  1. OncoTICE® powder for instillation fluid for intravesical use containing 2-8 x 108 CFU Tice BCG., N-803 (NAI), OncoTICE® 2-8 x 108 vermehrungsfähige Einheiten Pulver zur Herstellung einer Suspension zur intravesikalen Instillation

    Immunitybio

    Non-Muscle Invasive Bladder Cancer

    phase 2 small molecule active

    1 trial

Frequently asked questions

What is Immunitybio?

Immunitybio (E2736F2) is a pharma company. headquartered in GB. listed on EMA. NovaPharmaNews links 1 pipeline program, 0 drugs, and 0 patents to this profile..

What pipeline programs does Immunitybio sponsor?

We track 1 ClinicalTrials.gov-linked program for Immunitybio, including OncoTICE® powder for instillation fluid for intravesical use containing 2-8 x 108 CFU Tice BCG., N-803 (NAI), OncoTICE® 2-8 x 108 vermehrungsfähige Einheiten Pulver zur Herstellung einer Suspension zur intravesikalen Instillation. Open each program for phase, modality, NCT IDs, and indication details.

Where does Immunitybio company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.